On October 26, 2023, InMed Pharmaceuticals Inc. closed the transaction.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.27 USD | +0.78% | +3.09% | -35.10% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-35.10% | 1.62M | |
+4.34% | 106B | |
+6.81% | 23.47B | |
-14.17% | 21.9B | |
-7.05% | 18.77B | |
-38.55% | 17.85B | |
-8.37% | 16.78B | |
+7.52% | 14.41B | |
+38.54% | 12.86B | |
+322.46% | 8.78B |
- Stock Market
- Equities
- INM Stock
- News InMed Pharmaceuticals Inc.
- InMed Pharmaceuticals Inc. announced that it has received CAD 5.000002 million in funding